Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue:
Licensing revenue
Expenses:
Research and development	592,768	374	819,950	1,430
General and administrative	2,207,874	1,546,213	4,586,422	4,814,436
Total operating expenses	2,800,642	1,546,587	5,406,372	4,815,866
Loss before other income (expense)	(2,800,642)	(1,546,587)	(5,406,372)	(4,815,866)
Other income (loss):
Interest income	21,302	91,403	112,016	283,808
Other income (loss), net	4,782	(35,598)	5,522	(37,919)
Net loss from continuing operations	(2,774,558)	(1,490,782)	(5,288,834)	(4,569,977)
Income from discontinued operations		19,243		397,955
Net loss	$ (2,774,558)	$ (1,471,539)	$ (5,288,834)	$ (4,172,022)
Basic and diluted loss per share
Continuing operations	$ (0.08)	$ (0.04)	$ (0.16)	$ (0.14)
Discontinued operations				0.01
Total basic and diluted loss per share	$ (0.08)	$ (0.04)	$ (0.16)	$ (0.13)
Basic and diluted weighted-average shares outstanding	35,195,082	33,249,904	34,070,562	33,249,904